DNA damage response signaling

DDR Signaling - Damage Control Central

• Core Function: Senses DNA damage, halts the cell cycle to allow time for repair, or triggers apoptosis if damage is irreparable.
• Key Sensors (Kinases):
  • ATM (Ataxia-Telangiectasia Mutated): Activated primarily by Double-Strand Breaks (DSBs).
  • ATR (AT and Rad3-related): Responds to Single-Strand Breaks (SSBs) & stalled replication forks.
• Key Effector: p53 ("Guardian of the Genome") is stabilized, leading to transcription of cell cycle inhibitors (e.g., p21).

⭐ Li-Fraumeni syndrome, an autosomal dominant disorder with high cancer predisposition, is caused by germline mutations in the TP53 gene.

Sensors & Transducers - First Responders

• Sensors: Proteins that directly recognize DNA lesions or altered chromatin structures.
  • Double-Strand Breaks (DSBs): Detected by the MRN complex (MRE11-RAD50-NBS1).
  • Single-Strand Breaks (SSBs) & Stalled Forks: Recognized by RPA (Replication Protein A) and the 9-1-1 checkpoint clamp.
• Transducers: Key kinases that amplify the damage signal.
  • ATM (Ataxia-Telangiectasia Mutated): Recruited and activated by the MRN complex at DSBs.
  • ATR (ATM and Rad3-related): Recruited to RPA-coated ssDNA.
  • 📌 Mnemonic: ATM for MRN/DSBs; ATR for RPA/SSBs.

⭐ Ataxia-Telangiectasia results from ATM gene mutations. It presents with cerebellar ataxia, telangiectasias, immunodeficiency, and extreme sensitivity to ionizing radiation due to failed DSB repair signaling.

Effector Proteins - The Cleanup Crew

Once activated, the DDR signaling cascade triggers downstream effector proteins to manage the damage. The cell's fate-repair, arrest, or death-hangs in the balance, largely orchestrated by the master regulator, p53.

• Cell Cycle Arrest: Halts progression to prevent replication of damaged DNA.
  • p53 induces p21, which inhibits Cyclin-Dependent Kinases (CDKs).
  • Prevents G1/S and G2/M transitions.
• Apoptosis: Initiated when damage is too extensive for repair.
  • p53 upregulates pro-apoptotic proteins like BAX.
• DNA Repair: Activates and recruits the specific molecular machinery.
  • e.g., BRCA1, BRCA2 for homologous recombination.

⭐ Li-Fraumeni Syndrome: A rare, autosomal dominant disorder caused by a germline mutation in the TP53 gene. It leads to a significantly increased risk of developing multiple types of cancer at a young age.

Clinical Correlates - When Signals Cross

• Ataxia-Telangiectasia (AT)

  • Gene Defect: Autosomal recessive mutation in the ATM gene.
  • Pathophysiology: Defective dsDNA break sensing, leading to failed cell cycle arrest.
  • Clinical Triad: Cerebellar ataxia, oculocutaneous telangiectasias, and severe immunodeficiency.
  • Labs: ↑ alpha-fetoprotein (AFP), IgA deficiency.
  • ⚠️ Warning: Extreme sensitivity to ionizing radiation.

• Li-Fraumeni Syndrome

  • Gene Defect: Autosomal dominant mutation in the TP53 gene.
  • Pathophysiology: Loss of the "guardian of the genome" impairs apoptosis and cell cycle control.

⭐ Exam Favorite: TP53 mutations are found in over 50% of all human cancers, making it a critical tumor suppressor gene.

High‑Yield Points - ⚡ Biggest Takeaways

• ATM and ATR are the primary sensors; ATM for double-strand breaks and ATR for single-strand breaks.
• They activate the p53 tumor suppressor, the "guardian of the genome," via phosphorylation.
• p53 induces p21, which inhibits CDKs, leading to cell cycle arrest at G1/S or G2/M checkpoints, allowing time for repair.
• If damage is irreparable, p53 triggers apoptosis by upregulating proteins like BAX.
• Germline TP53 mutations cause Li-Fraumeni syndrome, predisposing to various cancers.